Back
Speaker illustration

undefined undefined undefined

Presentations Articles

12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Prevention

Session: Chronic coronary syndromes: pathophysiology, treatment, and prognosis

Access
Like
Thumbnail

Targeting inflammation with colchicine in patients with acute coronary syndromes.

Event: ACVC 2021

Topic: Acute Cardiac Care

Session: Inflammation and hypoxia as therapeutic targets in acute cardiovascular care

Access
Like
Thumbnail

LoDoCo2 - Colchicine in Patients With Chronic Coronary Disease

Event: ESC Congress 2020

Topic: Chronic Ischaemia

Session: Hot Line LoDoCo2

Access
Like
Thumbnail

Hot Line LoDoCo2.

Event: ESC Congress 2020

Topic: Chronic Ischaemia

Session: Hot Line LoDoCo2

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources